文献速递乳腺癌

初始诊疗集中化与贫困乳腺癌患者生存改善

Centralization of Initial Care and Improved Survival of Poor Patients With Breast Cancer.
PubMed 文献 · J Clin Oncol · 2023-01-05

研究利用纽约州2009年政策(每年乳腺癌手术量少于30例的机构不得为医疗补助受益人支付乳腺癌手术费用)作为自然实验,纳入37822例I-III期乳腺癌女性,采用多变量双重差分比较医疗补助患者与其他保险患者死亡率;政策后医疗补助患者乳腺癌死亡率由6.6%降至4.5%,其他患者由3.9%降至3.8%,生存获益显著更大。

要点

  • 政策后医疗补助患者5年总死亡率降幅显著大于其他保险患者(P = .018)。
  • 医疗补助患者乳腺癌特异性死亡率降幅大于其他患者(P = .005)。
  • 医疗补助患者其他原因死亡降幅未更大(P = .50),新泽西州医疗补助患者未观察类似效应。

核心结论

  • 全州性集中化政策不鼓励在低手术量机构进行乳腺癌初始诊疗,与目标医疗补助人群生存改善相关。
  • 作者认为,鉴于这些显著结果及既往研究,其他政策制定者应考虑采用类似政策以改善乳腺癌结局。

研究设计与样本

  • 利用纽约州2009年政策(每年乳腺癌手术量少于30例的机构不得为纽约医疗补助受益人支付乳腺癌手术费用)作为自然实验。
  • 识别2004-2008年或2010-2013年37822例I-III期乳腺癌女性,并链接至纽约医院出院数据。
  • 采用多变量双重差分方法,比较医疗补助参保患者与不受政策影响的商业或其他保险患者的死亡率。

主要发现

  • 政策后年份治疗女性的5年总死亡率略低于政策前,医疗补助患者生存获益显著更大(P = .018)。
  • 医疗补助患者乳腺癌特异性死亡率降幅大于其他患者(P = .005),但其他原因死亡降幅未更大(P = .50)。
  • 调整后医疗补助女性乳腺癌死亡率从政策前6.6%降至政策后4.5%,其他女性从3.9%降至3.8%。
  • 同年在同一年份治疗的新泽西州医疗补助乳腺癌患者未观察到类似效应。

临床怎么用

  • 作者认为其他政策制定者应考虑采用类似政策以改善乳腺癌结局。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Poor women with breast cancer have worse survival than others, and are more likely to undergo surgery in low-volume facilities. We leveraged a natural experiment to study the effectiveness of a policy intervention undertaken by New York (NY) state in 2009 that precluded payment for breast cancer surgery for NY Medicaid beneficiaries treated in facilities performing fewer than 30 breast cancer surgeries annually. METHODS: We identified 37,822 women with stage I-III breast cancer during 2004-2008 or 2010-2013 and linked them to NY hospital discharge data. A multivariable difference-in-differences approach compared mortality of Medicaid insured patients with that of commercially or otherwise insured patients unaffected by the policy. RESULTS: Women treated during the postpolicy years had slightly lower 5-year overall mortality than those treated prepolicy; the survival gain was significantly larger for Medicaid patients (P = .018). Women enrolled in Medicaid had a greater reduction than others in breast cancer-specific mortality (P = .005), but no greater reduction in other causes of death (P = .50). Adjusted breast cancer mortality among women covered by Medicaid declined from 6.6% to 4.5% postpolicy, while breast cancer mortality among other women fell from 3.9% to 3.8%. A similar effect was not observed among New Jersey Medicaid patients with breast cancer treated during the same years. CONCLUSION: A statewide centralization policy discouraging initial care for breast cancer in low-volume facilities was associated with better survival for the Medicaid population targeted. Given these impressive results and those from prior research, other policymakers should consider adopting comparable policies to improve breast cancer outcomes.[Media: see text].

来源:J Clin Oncol,查看原文。版权归原作者所有。

引用

  1. Nattinger AB, Bickell NA, Schymura MJ, et al. Centralization of Initial Care and Improved Survival of Poor Patients With Breast Cancer. J Clin Oncol. 2023. PMID: 36603178. doi:10.1200/JCO.22.02012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。